Crosstalk between circular RNAs and the STAT3 signaling pathway in human cancer

Mansour Almouh1, Chadi Soukkarieh2, Morshed Kassouha3

  • 1Department of Animal Production, Faculty of Veterinary Medicine, Hama University, Hama, Syria.

Insights

Circular RNAs (circRNAs) regulate the STAT3 signaling pathway in cancer. This review explores how circRNAs impact cancer progression and chemotherapy sensitivity via STAT3, offering new therapeutic insights.

Area of Science:

  • Molecular Biology
  • Oncology
  • RNA Biology

Background:

  • Circular RNAs (circRNAs) are RNA molecules formed by the circularization of pre-mRNA.
  • The STAT3 signaling pathway is crucial in human cancer development and progression.
  • Dysregulated circRNAs expression is observed in various cancers, influencing their roles as tumor suppressors or oncogenes.

Purpose of the Study:

  • To comprehensively review the molecular mechanisms of circRNA regulation of STAT3 signaling in cancer.
  • To explore the crosstalk between STAT3 signaling-related circRNAs and other cancer-related pathways.
  • To discuss the potential of the circRNA/STAT3 axis in cancer chemotherapy.

Main Methods:

  • Literature review of existing studies on circRNAs, STAT3 signaling, and cancer.
  • Analysis of molecular mechanisms linking circRNAs to STAT3 pathway modulation.
  • Synthesis of data on the role of circRNAs in cancer progression and treatment response.

Main Results:

  • CircRNAs can act as tumor suppressors or oncogenes by modulating STAT3 signaling.
  • Specific circRNAs interact with STAT3, influencing gene expression and cellular functions in cancer.
  • The circRNA/STAT3 axis is implicated in resistance and sensitivity to cancer chemotherapy.

Conclusions:

  • Understanding the circRNA-STAT3 interaction provides novel insights into cancer biology.
  • Targeting the circRNA/STAT3 axis may offer new therapeutic strategies for cancer treatment.
  • Further research into circRNAs' role in STAT3-driven malignancies is warranted.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K